These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21256035)

  • 1. Synthesis and SAR studies on azetidine-containing dipeptides as HCMV inhibitors.
    Pérez-Faginas P; Aranda MT; García-López MT; Snoeck R; Andrei G; Balzarini J; González-Muñiz R
    Bioorg Med Chem; 2011 Feb; 19(3):1155-61. PubMed ID: 21256035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anti-HCMV activity of 1-acyl-beta-lactams and 1-acylazetidines derived from phenylalanine.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; Balzarini J; De Clercq E; González-Muñiz R
    Bioorg Med Chem Lett; 2004 May; 14(9):2253-6. PubMed ID: 15081019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; De Clercq E; Balzarini J; González-Muñiz R
    J Med Chem; 2005 Apr; 48(7):2612-21. PubMed ID: 15801851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New inhibitors of human cytomegalovirus (HCMV) on the horizon.
    De Clercq E
    J Antimicrob Chemother; 2003 May; 51(5):1079-83. PubMed ID: 12697653
    [No Abstract]   [Full Text] [Related]  

  • 5. Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. study of structural requirements for biological activity.
    Martinez A; Gil C; Castro A; Pérez C; Prieto C; Otero J
    Bioorg Med Chem; 2003 May; 11(11):2395-402. PubMed ID: 12735985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzothiadiazine dioxide human cytomegalovirus inhibitors: synthesis and antiviral evaluation of main heterocycle modified derivatives.
    Martinez A; Gil C; Castro A; Bruno AM; Pérez C; Prieto C; Otero J
    Antivir Chem Chemother; 2003 Mar; 14(2):107-14. PubMed ID: 12856922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-HCMV activity of 1-[ω-(phenoxy)alkyl]uracil derivatives and analogues thereof.
    Novikov MS; Babkov DA; Paramonova MP; Khandazhinskaya AL; Ozerov AA; Chizhov AO; Andrei G; Snoeck R; Balzarini J; Seley-Radtke KL
    Bioorg Med Chem; 2013 Jul; 21(14):4151-7. PubMed ID: 23743443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel difluoro-cyclopropyl guanine nucleosides and their phosphonate analogues as potent antiviral agents.
    Li H; Yoo JC; Kim E; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):945-60. PubMed ID: 22060557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
    Zou R; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):802-10. PubMed ID: 9057867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein.
    Loregian A; Mercorelli B; Muratore G; Sinigalia E; Pagni S; Massari S; Gribaudo G; Gatto B; Palumbo M; Tabarrini O; Cecchetti V; Palù G
    Antimicrob Agents Chemother; 2010 May; 54(5):1930-40. PubMed ID: 20194695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzothiadiazine dioxide dibenzyl derivatives as potent human cytomegalovirus inhibitors: synthesis and comparative molecular field analysis.
    Martinez A; Gil C; Abasolo MI; Castro A; Bruno AM; Perez C; Prieto C; Otero J
    J Med Chem; 2000 Aug; 43(17):3218-25. PubMed ID: 10966740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of new potent human cytomegalovirus (HCMV) inhibitors based on internally hydrogen-bonded 1,6-naphthyridines.
    Chan L; Stefanac T; Lavallée JF; Jin H; Bédard J; May S; Falardeau G
    Bioorg Med Chem Lett; 2001 Jan; 11(2):103-5. PubMed ID: 11206437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azetidine derivatives as novel gamma-aminobutyric acid uptake inhibitors: synthesis, biological evaluation, and structure-activity relationship.
    Faust MR; Höfner G; Pabel J; Wanner KT
    Eur J Med Chem; 2010 Jun; 45(6):2453-66. PubMed ID: 20219271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of 2-substituent on the activity of imidazo[1,2-a] pyridine derivatives against human cytomegalovirus.
    Mavel S; Renou JL; Galtier C; Allouchi H; Snoeck R; Andrei G; De Clercq E; Balzarini J; Gueiffier A
    Bioorg Med Chem; 2002 Apr; 10(4):941-6. PubMed ID: 11836102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.
    de Castro S; Peromingo MT; Naesens L; Andrei G; Snoeck R; Balzarini J; Velázquez S; Camarasa MJ
    J Med Chem; 2008 Sep; 51(18):5823-32. PubMed ID: 18707089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of 3-formyl- and 3-cyano-2,5,6-trichloroindole nucleoside derivatives.
    Williams JD; Chen JJ; Drach JC; Townsend LB
    J Med Chem; 2004 Nov; 47(23):5766-72. PubMed ID: 15509175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment.
    Massari S; Mercorelli B; Sancineto L; Sabatini S; Cecchetti V; Gribaudo G; Palù G; Pannecouque C; Loregian A; Tabarrini O
    ChemMedChem; 2013 Aug; 8(8):1403-14. PubMed ID: 23757191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design.
    Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P
    Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein.
    Mercorelli B; Luganini A; Celegato M; Palù G; Gribaudo G; Loregian A
    Antiviral Res; 2018 Feb; 150():130-136. PubMed ID: 29274844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
    Oiknine-Djian E; Weisblum Y; Panet A; Wong HN; Haynes RK; Wolf DG
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.